ATXN1

gene product
ATX1, D6S504E, SCA1
The autosomal dominant cerebellar ataxias (ADCA) are a heterogeneous group of neurodegenerative disorders characterized by progressive degeneration of the cerebellum, brain stem and spinal cord. Clinically, ADCA has been divided into three groups: ADCA types I-III. ADCAI is genetically heterogeneous, with five genetic loci, designated spinocerebellar ataxia (SCA) 1, 2, 3, 4 and 6, being assigned to five different chromosomes. ADCAII, which always presents with retinal degeneration (SCA7), and ADCAIII often referred to as the `pure' cerebellar syndrome (SCA5), are most likely homogeneous disorders. Several SCA genes have been cloned and shown to contain CAG repeats in their coding regions. ADCA is caused by the expansion of the CAG repeats, producing an elongated polyglutamine tract in the corresponding protein. The expanded repeats are variable in size and unstable, usually increasing in size when transmitted to successive generations. The function of the ataxins is not known. This locus has been mapped to chromosome 6, and it has been determined that the diseased allele contains 41-81 CAG repeats, compared to 6-39 in the normal allele, and is associated with spinocerebellar ataxia type 1 (SCA1). At least two transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Jan 2010]
More gene data

Featured antibodies

Antibodies

 

Filters

Antibodypedia Validation Initiative

Validation method

Application

Reference

Provider

Host

Reactivity

Antibody type

Conjugate

  or   Clear
Enhanced validation
Supportive data in Antibodypedia
Data presented on provider website
Data in Antibodypedia (inconclusive)
Recommended by provider
Validated within AVI
Eligible for validation within AVI
619 antibodies from 36 providers.

Antibody properties

Applications

or Cancel
AntibodyRefsTypeAVIWBELICCIPIHCFC
antibodies-online
183 antibodies
GeneTex
10 antibodies
Novus Biologicals
36 antibodies
Acris Antibodies GmbH
8 antibodies
OriGene
7 antibodies
Abnova Corporation
4 antibodies
Affinity Biosciences
3 antibodies
Invitrogen Antibodies
5 antibodies
St John's Laboratory
7 antibodies
Boster Biological Technology
1 antibody
LifeSpan BioSciences, Inc.
95 antibodies
Biorbyt
62 antibodies
Aviva Systems Biology
4 antibodies
NovoPro Bioscience Inc.
3 antibodies
Abgent
5 antibodies
NSJ Bioreagents
2 antibodies
Bioworld Technology, Inc
1 antibody
Abbkine Scientific Co.Ltd.
2 antibodies
Bethyl Laboratories
2 antibodies
UC Davis/NIH NeuroMab Facility
6 antibodies
Creative Diagnostics
4 antibodies
Rockland Immunochemicals, Inc.
34 antibodies
Atlas Antibodies
2 antibodies
MyBioSource
15 antibodies
Creative Biolabs
4 antibodies
ProSci
4 antibodies
Signalway Antibody LLC
1 antibody
United States Biological
64 antibodies
RayBiotech, Inc.
2 antibodies
Abiocode, Inc.
1 antibody
Cell Signaling Technology, Inc
1 antibody
Sigma-Aldrich
1 antibody
Everest Biotech
2 antibodies
Abbiotec
1 antibody
EMD Millipore
1 antibody